Naturally Splendid (NSP.V) Completes Planning for Cavaltinib™ Trial
Naturally Splendid (NSP.V) has provided an update regarding a Health Canada approved clinical trial and strategic outlook for the development of Cavaltinib™. “We have been… Read More »Naturally Splendid (NSP.V) Completes Planning for Cavaltinib™ Trial



